The Effect of Pramlintide on Meal Time Insulin Bolus
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The primary objective is to establish the mean percentage of change in the
insulin-to-carbohydrate ratio due to pramlintide treatment once a maximum tolerated dose or 6
mcg before each meal is reached. The secondary objective is to establish which insulin bolus
wave form is associated with the lowest post-bolus without hypoglycemia in subjects treated
with maximum pramlintide dosage.